Correlation Between Elevai Labs, and Oncotelic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Elevai Labs, and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevai Labs, and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevai Labs, Common and Oncotelic Therapeutics, you can compare the effects of market volatilities on Elevai Labs, and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevai Labs, with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevai Labs, and Oncotelic Therapeutics.
Diversification Opportunities for Elevai Labs, and Oncotelic Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Elevai and Oncotelic is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Elevai Labs, Common and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Elevai Labs, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevai Labs, Common are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Elevai Labs, i.e., Elevai Labs, and Oncotelic Therapeutics go up and down completely randomly.
Pair Corralation between Elevai Labs, and Oncotelic Therapeutics
Given the investment horizon of 90 days Elevai Labs, Common is expected to under-perform the Oncotelic Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Elevai Labs, Common is 1.73 times less risky than Oncotelic Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Oncotelic Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Oncotelic Therapeutics on August 31, 2024 and sell it today you would lose (0.80) from holding Oncotelic Therapeutics or give up 26.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 12.36% |
| Values | Daily Returns |
Elevai Labs, Common vs. Oncotelic Therapeutics
Performance |
| Timeline |
| Elevai Labs, Common |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Elevai Labs, and Oncotelic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevai Labs, and Oncotelic Therapeutics
The main advantage of trading using opposite Elevai Labs, and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevai Labs, position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.| Elevai Labs, vs. Arrow Electronics | Elevai Labs, vs. WiMi Hologram Cloud | Elevai Labs, vs. Lion One Metals | Elevai Labs, vs. ACG Metals Limited |
| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |